Literature DB >> 21663334

Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel.

Saul N Weingart1, Andrew C Seger, Nicholas Feola, James Heffernan, Gordon Schiff, Thomas Isaac.   

Abstract

BACKGROUND: Computerized physician order entry systems are known to improve patient safety in acute-care hospitals. However, as clinicians frequently override drug interaction and allergy alerts, their value in ambulatory care remains uncertain.
OBJECTIVE: The purpose of the study was to examine whether ambulatory care clinicians were more likely to accept drug-drug interaction alerts that an expert panel judged to be of high clinical value. STUDY
DESIGN: We convened an expert panel to examine drug-drug interaction alerts generated by 2872 clinicians in Massachusetts, Pennsylvania and New Jersey who used a common electronic prescribing system between 1 January 2006 and 30 September 2006. We selected 120 representative drug interaction alerts from the most commonly encountered class-class interactions. MEASUREMENTS: The expert panel rated each alert based on the following categories: (i) strength of the scientific evidence; (ii) probability that the interaction would result in an adverse drug event (ADE); (iii) severity of typical and most serious ADEs; (iv) the likelihood that a clinician could act on the information; and (v) the overall value of the alert to the average primary care clinician. We then used multivariate regression techniques to examine the relationship between the alert acceptance rate and the expert panel's mean rating of each category.
RESULTS: The decision of clinicians to accept drug interaction alerts increased (relative to a baseline alert acceptance rate of 8.8%) by 2.7% (95% CI 0.4, 5.1) for interactions that panelists judged would result in an ADE, by 2.3% (95% CI 0.9, 3.7) when primary care providers (PCPs) lacked prior knowledge about the information presented in the alert, and by 3.3% (95% CI 0.9, 5.8) when the PCP could readily act on the information provided in the alert.
CONCLUSION: The value of electronic drug interaction alerts is influenced heavily by clinicians' judgements about the clinical value of the alert. Expert judgement should be taken into account when developing electronic decision support.

Entities:  

Mesh:

Year:  2011        PMID: 21663334     DOI: 10.2165/11589360-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  14 in total

1.  General practitioners' perceptions of the pharmaceutical decision-support tools in their prescribing software.

Authors:  Michael D Ahearn; Stephen J Kerr
Journal:  Med J Aust       Date:  2003-07-07       Impact factor: 7.738

2.  Concordance of severity ratings provided in four drug interaction compendia.

Authors:  Jacob Abarca; Daniel C Malone; Edward P Armstrong; Amy J Grizzle; Philip D Hansten; Robin C Van Bergen; Richard B Lipton
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Mar-Apr

3.  Improving acceptance of computerized prescribing alerts in ambulatory care.

Authors:  Nidhi R Shah; Andrew C Seger; Diane L Seger; Julie M Fiskio; Gilad J Kuperman; Barry Blumenfeld; Elaine G Recklet; David W Bates; Tejal K Gandhi
Journal:  J Am Med Inform Assoc       Date:  2005-10-12       Impact factor: 4.497

4.  Comparative assessment of four drug interaction compendia.

Authors:  Agnes I Vitry
Journal:  Br J Clin Pharmacol       Date:  2006-12-07       Impact factor: 4.335

5.  Practitioners' views on computerized drug-drug interaction alerts in the VA system.

Authors:  Yu Ko; Jacob Abarca; Daniel C Malone; Donna C Dare; Doug Geraets; Antoun Houranieh; William N Jones; W Paul Nichol; Gregory P Schepers; Michelle Wilhardt
Journal:  J Am Med Inform Assoc       Date:  2006-10-26       Impact factor: 4.497

6.  Overrides of medication alerts in ambulatory care.

Authors:  Thomas Isaac; Joel S Weissman; Roger B Davis; Michael Massagli; Adrienne Cyrulik; Daniel Z Sands; Saul N Weingart
Journal:  Arch Intern Med       Date:  2009-02-09

7.  Patient-reported medication symptoms in primary care.

Authors:  Saul N Weingart; Tejal K Gandhi; Andrew C Seger; Diane L Seger; Joshua Borus; Elisabeth Burdick; Lucian L Leape; David W Bates
Journal:  Arch Intern Med       Date:  2005-01-24

8.  The impact of computerized physician order entry on medication error prevention.

Authors:  D W Bates; J M Teich; J Lee; D Seger; G J Kuperman; N Ma'Luf; D Boyle; L Leape
Journal:  J Am Med Inform Assoc       Date:  1999 Jul-Aug       Impact factor: 4.497

9.  Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.

Authors:  Daniel C Malone; Jacob Abarca; Philip D Hansten; Amy J Grizzle; Edward P Armstrong; Robin C Van Bergen; Babette S Duncan-Edgar; Steven L Solomon; Richard B Lipton
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Mar-Apr

10.  A mixed method study of the merits of e-prescribing drug alerts in primary care.

Authors:  Kate L Lapane; Molly E Waring; Karen L Schneider; Catherine Dubé; Brian J Quilliam
Journal:  J Gen Intern Med       Date:  2008-04       Impact factor: 5.128

View more
  11 in total

Review 1.  Clinical decision support alert appropriateness: a review and proposal for improvement.

Authors:  Allison B McCoy; Eric J Thomas; Marie Krousel-Wood; Dean F Sittig
Journal:  Ochsner J       Date:  2014

Review 2.  Modulators Influencing Medication Alert Acceptance: An Explorative Review.

Authors:  Janina A Bittmann; Walter E Haefeli; Hanna M Seidling
Journal:  Appl Clin Inform       Date:  2022-08-18       Impact factor: 2.762

3.  Recommendations for selecting drug-drug interactions for clinical decision support.

Authors:  Hugh Tilson; Lisa E Hines; Gerald McEvoy; David M Weinstein; Philip D Hansten; Karl Matuszewski; Marianne le Comte; Stefanie Higby-Baker; Joseph T Hanlon; Lynn Pezzullo; Kathleen Vieson; Amy L Helwig; Shiew-Mei Huang; Anthony Perre; David W Bates; John Poikonen; Michael A Wittie; Amy J Grizzle; Mary Brown; Daniel C Malone
Journal:  Am J Health Syst Pharm       Date:  2016-04-15       Impact factor: 2.637

4.  Use of an on-demand drug-drug interaction checker by prescribers and consultants: a retrospective analysis in a Swiss teaching hospital.

Authors:  Patrick Emanuel Beeler; Emmanuel Eschmann; Christoph Rosen; Jürg Blaser
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

5.  Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.

Authors:  Jean-Pascal Fournier; Maryse Lapeyre-Mestre; Agnès Sommet; Julie Dupouy; Jean-Christophe Poutrain; Jean-Louis Montastruc
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

6.  An automated clinical alert system for newly-diagnosed atrial fibrillation.

Authors:  David A Cook; Felicity Enders; Pedro J Caraballo; Rick A Nishimura; Farrell J Lloyd
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Validation of a transparent decision model to rate drug interactions.

Authors:  Elmira Far; Ivanka Curkovic; Kelly Byrne; Malgorzata Roos; Isabelle Egloff; Michael Dietrich; Wilhelm Kirch; Gerd-A Kullak-Ublick; Marco Egbring
Journal:  BMC Pharmacol Toxicol       Date:  2012-08-20       Impact factor: 2.483

8.  Evaluation of a drug-drug interaction: fax alert intervention program.

Authors:  Edward P Armstrong; Sharon M Wang; Lisa E Hines; Sara Gao; Bimal V Patel; Daniel C Malone
Journal:  BMC Med Inform Decis Mak       Date:  2013-03-04       Impact factor: 2.796

9.  On the alert: future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshop.

Authors:  Jamie J Coleman; Heleen van der Sijs; Walter E Haefeli; Sarah P Slight; Sarah E McDowell; Hanna M Seidling; Birgit Eiermann; Jos Aarts; Elske Ammenwerth; Ann Slee; Robin E Ferner; Robin E Ferner; Ann Slee
Journal:  BMC Med Inform Decis Mak       Date:  2013-10-01       Impact factor: 2.796

10.  Variation in high-priority drug-drug interaction alerts across institutions and electronic health records.

Authors:  Dustin S McEvoy; Dean F Sittig; Thu-Trang Hickman; Skye Aaron; Angela Ai; Mary Amato; David W Bauer; Gregory M Fraser; Jeremy Harper; Angela Kennemer; Michael A Krall; Christoph U Lehmann; Sameer Malhotra; Daniel R Murphy; Brandi O'Kelley; Lipika Samal; Richard Schreiber; Hardeep Singh; Eric J Thomas; Carl V Vartian; Jennifer Westmorland; Allison B McCoy; Adam Wright
Journal:  J Am Med Inform Assoc       Date:  2017-03-01       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.